Showing results (11-20 of 158) with videos related to

Sort By:
Pageof 16
Drug Metabolism and Pharmacokinetics|December 27, 2007
Decreased renal accumulation and toxicity of a new VCM formulation in rats with chronic renal failureNaoko Hodoshima, Satohiro Masuda, Ken-Ichi Inui
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences|December 9, 2020
Inhibitory effects of vandetanib on creatinine transport via renal organic cation transporter OCT2Yuko Tanihara, Satohiro Masuda, Ken-Ichi Inui
Journal of Pharmacological Sciences|November 10, 2018
Riluzole prevents oxaliplatin-induced cold allodynia via inhibition of overexpression of transient receptor potential melastatin 8 in ratsShota Yamamoto, Nobuaki Egashira, Makoto Tsuda, et al.
Kidney International|July 12, 2002
Down-regulation of rat organic cation transporter rOCT2 by 5/6 nephrectomyLin Ji, Satohiro Masuda, Hideyuki Saito, et al.
Biochemical Pharmacology|June 24, 2003
Decreased expression of P-glycoprotein during differentiation in the human intestinal cell line Caco-2Maki Goto, Satohiro Masuda, Hideyuki Saito, et al.
Biochemical Pharmacology|May 12, 2009
Transport of guanidine compounds by human organic cation transporters, hOCT1 and hOCT2Naoko Kimura, Satohiro Masuda, Toshiya Katsura, et al.
American Journal of Physiology. Cell Physiology|July 18, 2008
Identification and functional characterization of a novel human and rat riboflavin transporter, RFT1Atsushi Yonezawa, Satohiro Masuda, Toshiya Katsura, et al.
Biochemical Pharmacology|August 8, 2009
mTOR inhibitor everolimus ameliorates progressive tubular dysfunction in chronic renal failure ratsShunsaku Nakagawa, Satohiro Masuda, Kumiko Nishihara, et al.
European Journal of Pharmacology|October 2, 2012
Involvement of autophagy in the pharmacological effects of the mTOR inhibitor everolimus in acute kidney injuryShunsaku Nakagawa, Kumiko Nishihara, Ken-ichi Inui, et al.
Pageof 16